FDA issued a Warning Letter to Chongqing Pharma Research Institute Co., Ltd. on 2/14/2017 as a result of this inspection.
483 Chongqing Pharma Research Institute May 2016

483 Chongqing Pharma Research Institute May 2016

Peter Baker FDA, Marijo Kambere FDA$119.00 - Available Now

FDA investigators audited the Chongqing Pharma Research Institute - Zhongqing, China facility and issued 3 inspectional observations (via FDA 483) on 19 May 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 19 May 2016
  • Location: Zhongqing, China
  • FEI: 3001204127
Add To Cart